We are international

Featured Videos
International Myeloma Working Group
Patient & Family Seminar Webcasts
IMF Webcasts from Medical Meetings
Myeloma Information
Nurse Leadership Board Webcasts
Myeloma Voices
The IMWG Conference Series "Making Sense of Treatment"
57th ASH Annual Meeting | Dec. 7, 2015

Drs. Brian GM Durie, Joseph Mikhael, Antonio Palumbo, and Paul Richardson discusses the latest news and trends in the treatment of Multiple Myeloma.

  • MRD Testing:  Is it Ready for Primetime?
  • Frontline Therapy:  What are the Best Option in 2015/2016
  • Relapse: How Do You Prioritize New Choices?
  • New Agents: Which Are Best and How Do We Assess? 
IMF Salamanca Flow Cytometry Workshop

The International Myeloma Foundation (IMF) and the EuroFlow consortium introduce a new automated and highly sensitive flow cytometry method for standardized detection of minimal residual disease (MRD) in myeloma patients.

IMWG - Report from ASH 2013 New Orleans

IMWG report from ASH 2013 New Orleans

4th Annual IMWG Summit: Key Questions
Stockholm report

The International Myeloma Working Group is the collaborative research body of the International Myeloma Foundation. Over 160 myeloma specialists meet annually to focus on key issues in myeloma research. The work of the IMWG has resulted in worldwide consensus on treatment protocols for myeloma patients. Going forward, the IMWG will incorporate findings from the IMF's Black Swan Research Initiative into their published guidelines.

What is the International Myeloma Working Group?
IMF's International Myeloma Working Group consists of 160 leading myeloma researchers from around the world who collaborate on a broad range of myeloma research projects. With a goal to improve myeloma treatment options and diagnostic systems, their work focuses on protocols to provide a more durable remission for myeloma patients while improving quality of life, addressing the needs of both myeloma patients and the physicians who treat them.